Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Merritt Edlind"'
Autor:
Lindsey Turr, Merritt Edlind, Judith A. Long, Shreya Kangovi, Karen Glanz, Tamala Carter, David Grande, Frances K. Barg, Nandita Mitra
Publikováno v:
Medical Care. 56:719-726
BACKGROUND: Half of all Americans have a chronic disease. Promoting healthy behaviors to decrease this burden is a national priority. A number of behavioral interventions have proven efficacy; yet even the most effective of these has high levels of n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02891e9de4c61ae2c42e854a7a13b88e
https://doi.org/10.1097/mlr.0000000000000939
https://doi.org/10.1097/mlr.0000000000000939
Autor:
Andrew C. Hsieh, Merritt Edlind
Publikováno v:
Asian Journal of Andrology, Vol 16, Iss 3, Pp 378-386 (2014)
Asian Journal of Andrology
Asian Journal of Andrology
Prostate cancer (PCa) is the second most common malignancy among men in the world. Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which develops upon resistance to first line androgen deprivation therapy (ADT). Emergin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87cdc21ca6703749404b08aaf7fb30c1
http://www.ajandrology.com/article.asp?issn=1008-682X
http://www.ajandrology.com/article.asp?issn=1008-682X
Autor:
Nicholas T. Ingolia, Matthew R. Janes, Andrew C. Hsieh, Craig R. Stumpf, Pingda Ren, Carly Christensen, Yi Liu, Kevan M. Shokat, Jonathan S. Weissman, Katti Jessen, Shunyou Wang, Michael Bonham, Christian Rommel, Michael C. Martin, Annie Sher, Evan Y. Shi, Davide Ruggero, Morris E. Feldman, Merritt Edlind
Publikováno v:
Nature. 485:55-61
The mammalian target of rapamycin (mTOR) kinase is a master regulator of protein synthesis that couples nutrient sensing to cell growth and cancer. However, the downstream translationally regulated nodes of gene expression that may direct cancer deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e571369edefcebdf1a9a0da786290bb
https://doi.org/10.1038/nature10912
https://doi.org/10.1038/nature10912
Autor:
Hao G. Nguyen, Davide Ruggero, Lexiaochuan Wen, Won Kim, Merritt Edlind, Andrew C. Hsieh, Peter R. Carroll
Publikováno v:
Science signaling, vol 8, iss 403
Pharmacological inhibitors against the PI3K-AKT-mTOR (phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin) pathway, a frequently deregulated signaling pathway in cancer, are clinically promising, but the development of drug resistance is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8484c47db71e7f18c16d362ccb0c5f7c
https://europepmc.org/articles/PMC4739654/
https://europepmc.org/articles/PMC4739654/
